Triochem Products reports standalone net loss of Rs 0.19 crore in the June 2022 quarter

Triochem Products reports standalone net profit of Rs 0.63 crore in the March 2022 quarter

Triochem Products reports standalone net loss of Rs 0.06 crore in the March 2021 quarter

Triochem Products reports standalone net loss of Rs 0.07 crore in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Profitability and efficiency haven't been upto the mark

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Triochem Products Limited is engaged in the manufacturing of chemical substances that are used in the manufacture of pharmaceuticals. The Company manufactures and exports pharmaceutical bulk drugs, active pharmaceutical ingredients and chemicals. 